{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T08:31:59Z","timestamp":1773736319016,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.es","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jdcr.2025.12.044","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:17:29Z","timestamp":1767629849000},"page":"201-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Acquired reactive perforating collagenosis treated with nemolizumab"],"prefix":"10.1016","volume":"69","author":[{"given":"Shehani T.","family":"Perera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Vescovacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Kaye","family":"Givens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5215-0559","authenticated-orcid":false,"given":"Andr\u00e1s","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austinn","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jdcr.2025.12.044_bib1","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/1346-8138.15647","article-title":"Clinical practice guide for the treatment of perforating dermatosis","volume":"47","author":"Kawakami","year":"2020","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2025.12.044_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2340\/00015555-2492","article-title":"Acquired reactive perforating dermatosis is a variant of prurigo nodularis","volume":"97","author":"Kestner","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/j.jdcr.2025.12.044_bib3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/ced\/llad119","article-title":"Perforating dermatosis in a patient on haemodialysis successfully treated with nemolizumab","volume":"48","author":"Ohmori","year":"2023","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"10.1016\/j.jdcr.2025.12.044_bib4","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1111\/jdv.19864","article-title":"A giant variant of acquired reactive perforating collagenosis successfully treated with nemolizumab","volume":"38","author":"Yamada","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.12.044_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/ajd.13874","article-title":"Reactive perforating collagenosis successfully treated with dupilumab","volume":"63","author":"Gil-Lianes","year":"2022","journal-title":"Australas J Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2025.12.044_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/toxins14030197","article-title":"The serum level of IL-31 in patients with chronic kidney disease-associated pruritus: what can we expect?","volume":"14","author":"\u015awierczy\u0144ska","year":"2022","journal-title":"Toxins (Basel)"},{"issue":"8","key":"10.1016\/j.jdcr.2025.12.044_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10157-021-02047-2","article-title":"Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase II, randomized, double-blind, placebo-controlled clinical study","volume":"25","author":"Kinugasa","year":"2021","journal-title":"Clin Exp Nephrol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:23:03Z","timestamp":1773728583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":7,"alternative-id":["S2352512626000032"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.12.044","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired reactive perforating collagenosis treated with nemolizumab","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.12.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}